Skip to contentS
Sensus Healthcare, Inc.
S
SRTSSensus Healthcare, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$13.07M$13.07Mderived+4.0% vs Q4 2023 Net Income$1.55M$1.55Mderived−63.3% vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sensus Healthcare, Inc. · CIK 1494891 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$7,106,000−9.2% Operating Incomederived$1,726,000−69.1% Operating Cash Flowderived-$827,000N/M Free Cash Flowderived-$530,000N/M Margins · derivedGross margin54.4%−7.9 pt vs Q4 2023
Operating margin13.2%−31.2 pt vs Q4 2023
Net margin11.8%−21.7 pt vs Q4 2023
ended Dec 31, 2024 · filed Mar 5, 2025 · 64 d after period end